Ge Huijian, Lv Xianli, Jin Hengwei, Tian Zhihua, Li Youxiang, He Hongwei
1 Department of Interventional Neuroradiology, Beijing Neurosurgical Institute, Capital Medical University, P.R. China.
2 Beijing Engineering Research Center for Interventional Neuroradiology, P.R. China.
Interv Neuroradiol. 2017 Feb;23(1):8-13. doi: 10.1177/1591019916665345. Epub 2016 Sep 22.
Objective This study was to evaluate the safety and efficiency of endovascular treatment of unruptured basilar tip aneurysms. Methods We retrospectively reviewed consecutive 79 cases of unruptured basilar tip aneurysms in our center between 2009 and 2014. The patients' clinical and imaging information were recorded. Complications, initial occlusion rate, clinical outcomes and the predictors were retrospectively analyzed. Results Thirty-five cases received conservative treatment and 44 cases were treated by endovascular embolization. In the conservative treatment group, six (19.4%) of 31 basilar tip aneurysms ruptured and resulted in five deaths (16.1%) during the mean 18.1-month follow-up (range from 1 to 60 months). Among the endovascularly treated cases, 24 (54.5%) achieved initial complete occlusion and no delayed hemorrhagic events occurred during the mean 33.6-month follow-up (range from 10 to 68 months). For 20 (45.5%) incompletely occluded cases, five postoperative or delayed hemorrhagic events and two mass effect events resulted in six deaths. There were no statistical significant differences in hemorrhagic events ( p = 0.732) and mortality ( p = 0.502) between the incomplete occlusion group and untreated group. Large aneurysm size (≥10 mm) was an independent predictor for incomplete occlusion ( p = 0.002), which had a potential risk of postoperative or delayed hemorrhage. On univariate analysis, initial occlusion rate and aneurysm size were found to be associated with clinical outcomes ( p = 0.042 and 0.015). Conclusion Complete occlusion for unruptured basilar tip aneurysm proved to be a safe and effective therapeutic method that could eliminate the potential risk of postoperative or delayed hemorrhage.
目的 本研究旨在评估未破裂基底动脉尖部动脉瘤血管内治疗的安全性和有效性。方法 我们回顾性分析了2009年至2014年期间在本中心连续收治的79例未破裂基底动脉尖部动脉瘤患者。记录患者的临床和影像学信息。对并发症、初始闭塞率、临床结局及预测因素进行回顾性分析。结果 35例患者接受保守治疗,44例患者接受血管内栓塞治疗。在保守治疗组中,31例基底动脉尖部动脉瘤中有6例(19.4%)破裂,在平均18.1个月的随访期(1至60个月)内导致5例死亡(16.1%)。在接受血管内治疗的病例中,24例(54.5%)实现了初始完全闭塞,在平均33.6个月的随访期(10至68个月)内未发生延迟性出血事件。对于20例(45.5%)未完全闭塞的病例,5例术后或延迟性出血事件及2例占位效应事件导致6例死亡。未完全闭塞组与未治疗组在出血事件(p = 0.732)和死亡率(p = 0.502)方面无统计学显著差异。动脉瘤较大(≥10 mm)是未完全闭塞的独立预测因素(p = 0.002),具有术后或延迟出血的潜在风险。单因素分析发现,初始闭塞率和动脉瘤大小与临床结局相关(p = 0.042和0.015)。结论 未破裂基底动脉尖部动脉瘤的完全闭塞被证明是一种安全有效的治疗方法,可消除术后或延迟出血的潜在风险。